We are live on ! Find out more
RXST icon

RxSight

212 hedge funds and large institutions have $1.21B invested in RxSight in 2024 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 85 increasing their positions, 61 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,042% more call options, than puts

Call options by funds: $19.8M | Put options by funds: $1.73M

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

39% more repeat investments, than reductions

Existing positions increased: 85 | Existing positions reduced: 61

2.11% more ownership

Funds ownership: 85.54%87.65% (+2.1%)

1% less funds holding

Funds holding: 214212 (-2)

5% less first-time investments, than exits

New positions opened: 40 | Existing positions closed: 42

28% less capital invested

Capital invested by funds: $1.68B → $1.21B (-$464M)

Holders
212
Holders Change
-2
Holders Change %
-0.93%
% of All Funds
2.79%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
40
Increased
85
Reduced
61
Closed
42
Calls
$19.8M
Puts
$1.73M
Net Calls
+$18.1M
Net Calls Change
-$3.51M
Name Holding Trade Value Shares
Change
Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$129M -$7.84M -173,807 -4%
BlackRock
2
BlackRock
New York
$102M +$8.31M +184,342 +7%
Vanguard Group
3
Vanguard Group
Pennsylvania
$81.9M +$4.35M +96,464 +4%
Bank of America
4
Bank of America
North Carolina
$74.3M +$18.7M +413,737 +24%
Artisan Partners
5
Artisan Partners
Wisconsin
$53.3M +$17.2M +381,389 +33%
Fidelity Investments
6
Fidelity Investments
Massachusetts
$37.6M -$4.89M -108,475 -9%
Millennium Management
7
Millennium Management
New York
$34.6M +$19.8M +440,071 +78%
Citadel Advisors
8
Citadel Advisors
Florida
$34.2M +$35.3M +782,424 +370%
State Street
9
State Street
Massachusetts
$30.6M +$3.3M +73,128 +9%
BCM
10
Brown Capital Management
Maryland
$29M +$13.5M +299,755 +55%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$28.6M +$615K +13,641 +2%
DSCM
12
Divisadero Street Capital Management
Florida
$27.9M +$1.75M +38,895 +5%
Deutsche Bank
13
Deutsche Bank
Germany
$22.6M +$480K +10,634 +2%
Credit Agricole
14
Credit Agricole
France
$20.4M +$26.7M +592,031 New
Royal Bank of Canada
15
Royal Bank of Canada
Ontario, Canada
$17.5M +$22.2M +492,574 +3,095%
NSGL
16
No Street GP LP
California
$17.2M +$1.13M +25,000 +5%
GGHC
17
Gilder Gagnon Howe & Co
New York
$14.6M -$7.27M -161,201 -27%
DDC
18
DF Dent & Co
Maryland
$14.5M +$19.1M +422,446 New
ACM
19
Atika Capital Management
New York
$14M -$90.2K -2,000 -0.5%
Northern Trust
20
Northern Trust
Illinois
$13.9M +$1.18M +26,106 +7%
Baillie Gifford & Co
21
Baillie Gifford & Co
United Kingdom
$13.7M -$906K -20,097 -5%
Morgan Stanley
22
Morgan Stanley
New York
$13.5M -$4.27M -94,701 -19%
Point72 Asset Management
23
Point72 Asset Management
Connecticut
$13.5M -$2.49M -55,244 -12%
Invesco
24
Invesco
Georgia
$13.4M -$26.9M -596,434 -60%
Voloridge Investment Management
25
Voloridge Investment Management
Florida
$12.6M +$9.59M +212,599 +139%

RXST Hedge Fund Activity: Q4 2024 in Review

212 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in RxSight (RXST) for Q4 2024, worth a combined $1.21B — down 28% from $1.68B a quarter earlier.

Sellers outnumbered buyers: 42 funds closed out of RXST and 40 opened new positions — a net loss of 2 holders — while 61 trimmed existing stakes and 85 added.

The largest buyer was Citadel Advisors, adding an estimated $35.3M. The largest seller was Lord, Abbett & Co, exiting entirely with an estimated $51.9M sold.

  • 212 institutional investors held RxSight (RXST) as of Q4 2024, down from 214 in Q3 2024.
  • Funds reported $1.21B of RxSight stock for Q4 2024, down 28% quarter-over-quarter.
  • 40 funds opened new RxSight positions in Q4 2024 and 42 closed out, a net change of -2 holders.
  • The largest RxSight buyer in Q4 2024 was Citadel Advisors, an estimated $35.3M added.
  • The largest RxSight seller in Q4 2024 was Lord, Abbett & Co, an estimated $51.9M sold.

Based on aggregated 13F filings for Q4 2024.